Express Interest in Neurocarrus

Neurocarrus

Neurocarrus

Neurocarrus, with a valuation of $11.25 million, is raising funds on Wefunder. The company has developed the drug candidate N-001 to provide neuron-specific pain relief without risk of addiction. Neurocarrus’ N-001 is a first-in-class, long-acting aesthetic-like drug that could reduce or avoid opioi...

0/500

Password should be at least 8 characters long.

Cancel

We use cookies on this site to enhance your user experience and analyze site traffic. By clicking "Accept", you consent to our use of cookies. Read our cookie policy